Healthy returns: FDA chief Marty Makary on compounded GLP-1s, vaccines and China

Makary helms the FDA in the midst of a contentious stretch for the agency, defined by massive staff and budget cuts and ...
Yicai Global

Kangtai Drops Plan to Set Up USD400 Million Vaccine JV With AstraZeneca in Beijing

(Yicai) Feb. 9 -- Kangtai Biological Products said it has terminated the Chinese vaccine maker's plan to establish a joint venture with UK-Swedish drugmaker AstraZeneca in Beijing that had a planned ...
Naija Gist - Latest

China embarks on clinical trial for virus vaccine

China has started the first phase of a clinical trial for a novel coronavirus vaccine, records show, as the world's scientists race to find a way to combat the deadly pathogen. It comes after US ...
FNArena

Delonix Bioworks Announces IND Clearance for DX-104, a Novel Engineered MenB OMV Vaccine Candidate, in China and Australia

Delonix Bioworks, a clinical-stage biotechnology company developing next-generation bacterial vaccines, recently ...
The Manila Times

DIFF Biotech's Innovative Nasal Spray Influenza Vaccine Receives Clinical Trial Approval, Introducing a New Attenuation Pathway

Zhejiang Difference Biological Technology Co., Ltd. (DIFF Biotech) announced that its proprietary nasal spray influenza attenuated live vaccine, DIFF-flu, has recently received clinical trial approval ...